<DOC>
	<DOC>NCT02932553</DOC>
	<brief_summary>The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.</brief_summary>
	<brief_title>BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina Pectoris, Variant</mesh_term>
	<criteria>Age 19 and more Vasospastic angina diagnosed by provocation test including ergonovine provocation coronary angiography or ergonovine echocardiogram Noischemia producing moderate coronary artery disease(stenosis&gt;50%, FFR&gt;0.8) Ischemic coronary lesion Organic heart disease associated with myocardial ischemia or sudden cardiac death History of percutaneous coronary intervention Cerebrovascular diseases or peripheral disease NYHA III and IV Cardiac pacemaker or implantable defibrillator Pregnancy or breast feeding Life expectancy less than 2 years</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>bioresorbable vascular scaffold</keyword>
	<keyword>variant angina</keyword>
	<keyword>moderate coronary artery disease</keyword>
	<keyword>vasospastic angina</keyword>
</DOC>